BusinessMedical Marijuana, Inc.’s HempMeds® Spokesperson Penny Howard Sees Daughter Harper’s Legacy at UCSD on What Would Have Been Her 6th BirthdayBy Nasdaq OMXApr 7, 2016, 1:00 PM UTC
BusinessMedical Marijuana, Inc. Appoints Blake N. Schroeder, Esq., As Vice President of OperationsBy Nasdaq OMXMar 29, 2016, 1:00 PM UTC
BusinessMedical Marijuana, Inc. Portfolio Investment Company, Kannalife Sciences, Inc. Notified of DEA Clearance for Import of High-Purity, Pharmaceutical-Grade Cannabidiol (CBD)By Nasdaq OMXMar 1, 2016, 2:00 PM UTC
BusinessMedical Marijuana, Inc. Portfolio Investment Company, Kannalife Sciences, Inc.’s New Cannabis-Derived Compound KLS-13019 Covered by Reuters, Kannalife Explores IPO This YearBy Nasdaq OMXFeb 26, 2016, 2:00 PM UTC
BusinessMedical Marijuana, Inc. Investment – AXIM Biotech – Lays Out Powerhouse IP Pipeline, Cannabinoid R&D in InterviewBy Nasdaq OMXFeb 25, 2016, 2:00 PM UTC
BusinessMedical Marijuana, Inc.’s HempMeds® México Offers Details for Importation of RSHO-X When Purchased in the U.S.By Nasdaq OMXFeb 24, 2016, 2:00 PM UTC
BusinessMedical Marijuana, Inc.’s Zero-THC Cannabidiol (CBD) Hemp Oil, RSHO-X™ From HempMeds®, Featured at Southwest Cannabis Conference in Fort Worth, TXBy Nasdaq OMXFeb 22, 2016, 2:00 PM UTC
BusinessMedical Marijuana, Inc. Portfolio Investment Company, Kannalife Sciences, Inc. Receives Publication Through American Chemical Society for KLS-13019, a Novel Cannabidiol-Derived Target Drug Candidate for Hepatic EncephalopathyBy Nasdaq OMXFeb 18, 2016, 2:00 PM UTC
